在低收入和中等收入国家的结核病护理,通过数字化坚持技术加强
Rabbyia Ahmad1,2, João Pedro Ramos3,4,2, Raquel Duarte3,4,5
1Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Minden Heights, Malaysia.
Breathe (Sheffield, England)
|February 19, 2026
概括
数字坚持技术 (DATs) 对改善低收入和中等收入国家 (LMICs) 结核病治疗的坚持有希望. 然而,成功实施需要解决全球结核病消除的成本,公平性和特定环境的挑战.
科学领域:
- 公共卫生 公共卫生
- 卫生技术评估 卫生技术评估
- 全球健康 全球健康
背景情况:
- 结核病 (TB) 是一个重要的全球卫生问题,特别是在LMICs.
- 坚持治疗对于控制结核病至关重要,但仍然是一个挑战.
- 数字坚持技术 (DAT) 为改善结核病护理提供了潜在的解决方案.
研究的目的:
- 评估DAT在提高LMICs的结核病治疗遵守率方面的作用和挑战.
- 评估DAT实施的成本效益和公平性影响.
- 确定成功采用和扩展DAT的策略.
主要方法:
- 对结核病治疗坚持的DATs现有文献的审查.
- 从各种LMIC环境中分析成本效益数据.
- 审查公平性问题,包括干预产生的不平等.
- 确定实施的挑战和促进者.
主要成果:
- DAT显示了改善结核病治疗坚持的潜力,一些低成本的选择如99DOTS正在出现.
- 在不同的LMIC中,成本效益的发现是混合的.
- 根据目标和背景,DAT的实施可以加剧或减轻健康不平等.
- 挑战包括基础设施,成本,技术疲劳,数据隐私和社会经济因素.
结论:
- DAT可以提高LMICs的结核病护理和坚持,但需要特定的背景策略.
- 解决公平问题和根据当地需求调整干预措施对于成功至关重要.
- 全球卫生倡议和资金对于扩大用于消除结核病的DAT至关重要.
相关概念视频
Pulmonary Tuberculosis V
656
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
656
Pulmonary Tuberculosis I
1.0K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.0K
Pulmonary Tuberculosis IV
557
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
557
Therapeutic Drug Monitoring: Affecting Factors
258
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
258
Pulmonary Tuberculosis II
1.7K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.7K
Pulmonary Tuberculosis III
1.1K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.1K


